Comments

Gilead Sciences Stock Price, Quotes and Forecasts

GILDNASDAQ
Logo brought to you by Benzinga Data
Trade with Public
Trade with Public
Last update: 10:03 AM

Gilead Sciences (GILD) Forecast

NewsEarningsOptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestGovernment TradesStock Report
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Gilead Sciences Stock Price, Quotes and Forecasts | NASDAQ:GILD | Benzinga

Explore Gilead Sciences stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for GILD.

Open$118.75
Close-
Volume / Avg.478.58K / 6.63M
Day Range$117.49 - $118.86
52 Wk Range84.17 - 121.83
Market Cap$146.66B
P/E Ratio23.46
Dividend Yield2.67%
ExchangeNASDAQ
RSI
61
Short Interest
1.47%
Days to Cover2.66

Recent News

Gilead Reaches Settlement To Block Biktarvy Generics Until 2036
Gilead Sciences settled patent disputes with Lupin, Cipla, and Laurus, delaying U.S. generic entry of HIV drug Biktarvy until April 2036.
Vandana Singh
These 3 Pharma Stocks Are Rallying – And Still Trade Absurdly Cheap
Health care stocks are rallying, but Pfizer, Merck and Bristol-Myers still trade below 10x forward P/E — a rare market discount.
Piero Cingari
Beating The September Curse–These 10 Stocks Shine While The S&P 500 Stumbles
September is historically the worst month for stocks, but these 10 S&P 500 companies have consistently delivered gains.
Piero Cingari
40%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trends and Forecast
1
Jul
1
1
Aug
1
Sep
1
Oct
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.8
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
Open$118.75
Close-
Volume / Avg.478.58K / 6.63M
Day Range$117.49 - $118.86
52 Wk Range84.17 - 121.83
Market Cap$146.66B
P/E Ratio23.46
Dividend Yield2.67%
ExchangeNASDAQ
RSI
61
Short Interest
1.47%
Days to Cover2.66
About Gilead Sciences Inc
Sector
Health Care
Industry
Biotechnology
Gilead Sciences develops and markets therapies to treat and prevent life-threatening infectious dise...
Show More

Compare

EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
GILD
ONC

FAQ

Q

How do I buy Gilead Sciences (GILD) stock?

A

You can purchase shares of Gilead Sciences (NASDAQ:GILD) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Gilead Sciences (GILD) competitors?

A

Other companies in Gilead Sciences’s space includes: BeOne Medicines (NASDAQ:ONC), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX), Ionis Pharmaceuticals (NASDAQ:IONS) and Roivant Sciences (NASDAQ:ROIV).

Q

What is the forecast, or price target, for Gilead Sciences (GILD) stock?

A

Gilead Sciences has a consensus price target of $110.36.

Q

What is the current price for Gilead Sciences (GILD)?

A

The stock price for Gilead Sciences (NASDAQ: GILD) is $118.195 last updated October 9, 2025 at 10:03 AM EDT.

Q

Does Gilead Sciences (GILD) pay a dividend?

A

A quarterly cash dividend of 0.79 per share of Class A Common Stock. The quarterly cash dividend was payable on September 29, 2025 to stockholders of record on September 15, 2025.

Q

When is Gilead Sciences (NASDAQ:GILD) reporting earnings?

A

Gilead Sciences’s Q3 earnings are confirmed for Wednesday, November 5, 2025.

Q

Is Gilead Sciences (GILD) going to split?

A

There is no upcoming split for Gilead Sciences.

Q

What sector and industry does Gilead Sciences (GILD) operate in?

A

Gilead Sciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2025 Benzinga | All Rights Reserved